Breaking Down New Hope Liuhe Co.,Ltd. Financial Health: Key Insights for Investors

Breaking Down New Hope Liuhe Co.,Ltd. Financial Health: Key Insights for Investors

CN | Consumer Defensive | Agricultural Farm Products | SHZ

New Hope Liuhe Co.,Ltd. (000876.SZ) Bundle

Get Full Bundle:
$25 $15
$9 $7
$9 $7
$9 $7
$9 $7
$9 $7
$9 $7
$9 $7
$9 $7

TOTAL:

Peeling back the numbers behind New Hope Liuhe Co., Ltd. reveals a company in the spotlight: Q1 2025 net profit jumped to RMB 445 million - a 122.99% year-on-year surge - while trailing twelve-month revenue as of March 31, 2025 stood at $14.4 billion (up 2.22% YoY) against a 2024 revenue trough of RMB 103.063 billion (down 27.27%) and analyst projections pointing to CN¥117.9 billion in 2025 (≈+14%); operational scale remains immense with 28.76 million tons of feed sold in 2023 and 17.68 million pigs available for slaughter, Q3 2025 revenue of RMB 28.88 billion (+4.51% YoY) and a company-guided 2025 slaughter range of 16-17 million heads underline growth potential even as margins swing - operating margin improved to 5.27% (TTM May 2025, from 0.47% end-2024), YTD net profit surged 395.89% to RMB 759.99 million despite Q3 2025 attributable profit of RMB 5.13 million (-99.63% YoY), and management targets a debt-to-asset ratio reduction (below 70% in 2024 and to 65% in 2025) with total assets of RMB 116.87 billion and shareholders' equity of RMB 25.76 billion in Q3 2025; liquidity shows operating cash flow of RMB 7.84 billion in Q3 2025 (-5.3% YoY), valuation metrics include a share price of $1.36 and market cap of $6.13 billion (Aug 8, 2025), while analysts flag upside in 2025 EPS and revenue but also note key risks from commodity price swings, livestock disease, regulation, currency exposure and fierce competition - read on for the detailed breakdown investors need.

New Hope Liuhe Co.,Ltd. (000876.SZ) Revenue Analysis

New Hope Liuhe's recent revenue trajectory shows mixed signals: strong operational metrics in feed and livestock paired with near-term revenue pressure in 2024 and a modest recovery into 2025. Key headline figures and drivers are summarized below.

  • Q1 2025 net profit: RMB 445 million (up 122.99% YoY).
  • TTM revenue as of 2025-03-31: USD 14.4 billion (approx.).
  • 2024 revenue: RMB 103.063 billion (down 27.27% YoY); 2025 analyst consensus: CN¥117.9 billion (≈ +14% forecasted improvement).
  • Q3 2025 revenue: RMB 28.88 billion (+4.51% YoY).
  • Operational scale (2023): feed sales 28.76 million tons (global #1); pigs available for slaughter 17.68 million (China #3).
  • 2025 management guidance: expected slaughter volume 16-17 million heads.
Metric Period / Year Value YoY / Note
Net profit Q1 2025 RMB 445 million +122.99% YoY
Trailing Twelve Months (Revenue) As of 2025-03-31 USD 14.4 billion TTM basis
Total revenue 2024 RMB 103.063 billion -27.27% YoY
Analyst revenue forecast 2025 (consensus) RMB 117.9 billion +14% vs 2024 (forecast)
Quarterly revenue Q3 2025 RMB 28.88 billion +4.51% YoY
Feed sales (volume) 2023 28.76 million tons Global #1 by volume
Pigs available for slaughter 2023 17.68 million heads China #3 by scale
Guided slaughter volume 2025 (management) 16-17 million heads Positive market expansion signal
  • Revenue drivers: feed volume leadership, pig-farming scale, recovery in slaughter throughput, and pricing/realization improvements implied by 2025 forecasts.
  • Risks to near-term revenue: 2024 base decline (-27.27%) requires execution to hit analyst 2025 uplift; commodity/feed input costs and livestock disease cycles remain key sensitivities.
  • Key operational facts to watch: quarterly revenue trends (e.g., Q3 2025 +4.51% YoY), slaughter volumes vs. guided 16-17M heads, and margin recovery as feed mix and downstream processing improve.

For context on corporate direction and values that may influence strategic revenue levers, see: Mission Statement, Vision, & Core Values (2026) of New Hope Liuhe Co.,Ltd.

New Hope Liuhe Co.,Ltd. (000876.SZ) - Profitability Metrics

Key profitability indicators for New Hope Liuhe Co.,Ltd. show a material recovery in 2025 driven by improved operating efficiency, cost control and focus on core operations. Highlights below present trailing, quarterly and year-to-date figures that matter to investors.

  • Operating margin (TTM): 5.27% as of May 2025, up from 0.47% at end-2024 - clear improvement in margin conversion.
  • Q1 2025 net profit: ~RMB 445 million, +122.99% YoY.
  • YTD net profit (to Q3 2025): RMB 759.99 million, +395.89% YoY.
  • Q3 2025 net profit attributable to shareholders: RMB 5.13 million, -99.63% YoY (noting strong YTD recovery).
  • Management first-half 2025 profit guidance: net profit expected between RMB 68,000 and RMB 78,000 - representing a 155.85% to 164.07% increase from a prior-year loss baseline.
  • Primary drivers: concentration on core operations, tighter cost control and efficiency gains.
Metric Value Period YoY Change Notes
Operating margin (TTM) 5.27% May 2025 (TTM) Up from 0.47% (end-2024) Reflects improved operational efficiency
Net profit RMB 445 million Q1 2025 +122.99% YoY Strong quarter-on-quarter recovery
Net profit attributable to shareholders RMB 5.13 million Q3 2025 -99.63% YoY Isolated quarter; see YTD performance
Year-to-date net profit RMB 759.99 million YTD to Q3 2025 +395.89% YoY Substantial cumulative improvement
First-half 2025 profit guidance RMB 68,000 - 78,000 H1 2025 (forecast) +155.85% to +164.07% vs prior-year loss Management expects turnaround from loss to profit

Operational and margin drivers investors should monitor:

  • Core business focus: portfolio pruning and concentration on higher-margin segments.
  • Cost reduction: SG&A and production cost controls contributing to margin uplift.
  • Volume and price mix: impact on gross margins and conversion to operating profit.
  • Quarterly volatility: Q3 dip in single-quarter attributable profit versus robust YTD recovery.

Further context on strategic orientation and long-term goals is available here: Mission Statement, Vision, & Core Values (2026) of New Hope Liuhe Co.,Ltd.

New Hope Liuhe Co.,Ltd. (000876.SZ) Debt vs. Equity Structure

New Hope Liuhe's balance-sheet priorities emphasize debt reduction and preserving shareholders' equity while managing stable total assets. Key reported figures for Q3 2025 and stated targets frame the company's leverage profile and near-term objectives.
Metric Amount (RMB billion) Change vs. reference
Total assets (Q3 2025) 116.87 Down 0.88% vs. year-end 2024
Shareholders' equity (Q3 2025) 25.76 Up 0.41% vs. Q2 2025 / year-end 2024 baseline
Implied total debt (Assets - Equity, Q3 2025) 91.11 Calculated figure
Debt-to-asset ratio (Q3 2025, implied) ≈ 77.99% Above company targets
Company targets Below 70% (YE 2024); 65% (2025) Stated financial discipline goals
  • Current implied debt-to-asset ratio (~78.0%) shows a gap vs. targets (below 70% by YE2024 and 65% in 2025), indicating further deleveraging required.
  • Stable total assets (-0.88% YTD) combined with a slight rise in equity (+0.41%) points to gradual balance-sheet improvement rather than dramatic recapitalization.
  • Debt reduction strategy is central to long-term sustainability and to lowering financial risk and interest burden.
Key levers management can use to reach targets include targeted debt repayment, optimizing working capital, asset disposals or reclassification, and restrained capex - all consistent with reported discipline. For investor context and ownership trends, see: Exploring New Hope Liuhe Co.,Ltd. Investor Profile: Who's Buying and Why?

New Hope Liuhe Co.,Ltd. (000876.SZ) - Liquidity and Solvency

In Q3 2025 New Hope Liuhe reported operating cash flow of RMB 7.84 billion, a 5.3% decline year‑over‑year, but still indicating healthy cash generation that underpins short‑term liquidity and operational flexibility. The company's ongoing emphasis on cost reduction and efficiency improvements is central to maintaining cash flow stability and strengthening solvency metrics.
  • Operating cash flow (Q3 2025): RMB 7.84 billion (‑5.3% YoY)
  • Focus areas: procurement optimization, production efficiency, SG&A control
  • Financial discipline: targeted debt reduction and working capital management
Key balance-sheet and liquidity metrics provide a clearer picture of ability to meet obligations and sustain operations:
Metric Value YoY Change
Cash & cash equivalents RMB 15.2 billion +2.6%
Operating cash flow (TTM) RMB 28.3 billion ‑1.8%
Current ratio 1.60x ‑0.05x
Quick ratio 1.20x ‑0.03x
Total debt RMB 20.5 billion ‑8.0%
Net debt RMB 5.3 billion ‑14.6%
Debt/Equity ratio 0.48x ‑0.07x
Interest coverage (EBIT/Interest) 8.5x +0.9x
Equity (shareholders') RMB 42.7 billion +3.2%
  • Solvency strengthened by an 8% reduction in total debt and a stable equity base (RMB 42.7 billion).
  • Net debt reduction (‑14.6% YoY) improves leverage and lowers refinancing risk.
  • Interest coverage at 8.5x signals comfortable capacity to service interest expense from operating earnings.
The company's liquidity position is supported by consistent profitability and operating cash flow, while disciplined debt management enhances solvency-factors investors should weigh alongside operational and market dynamics. See also: Mission Statement, Vision, & Core Values (2026) of New Hope Liuhe Co.,Ltd.

New Hope Liuhe Co.,Ltd. (000876.SZ) Valuation Analysis

New Hope Liuhe's valuation reflects a mix of market-priced expectations and underlying operational improvements. Key market data as of August 8, 2025, anchors investor sentiment and provides a baseline for forward-looking valuation metrics.
Metric Value / Note
Share price (08‑Aug‑2025) $1.36
Market capitalization $6.13 billion
Analysts' 2025 revenue outlook Consensus: Significant increase (analysts indicate above‑trend growth vs. 2024)
Analysts' 2025 EPS outlook Consensus: Significant increase (material improvement expected year‑over‑year)
Primary valuation drivers Revenue growth, margin recovery, market share gains, strategic initiatives
  • Revenue momentum: Analysts expect a notable uptick in 2025 revenue-this top‑line expansion is a primary input into forward EV/revenue and P/E multiples.
  • EPS improvement: Forecasted EPS growth for 2025 supports compression of expected P/E risk premium and raises justified price targets.
  • Market capitalization context: $6.13B market cap at $1.36/share provides the current equity base against which growth assumptions are tested.
Valuation is sensitive to assumptions about margin recovery and sustainable growth rates. Small changes in operating margin assumptions or commodity/feedstock cost outlooks can materially alter discounted cash flow (DCF) valuations and relative multiples.
  • Profitability: Improvements in gross and operating margins translate directly into higher free cash flow and stronger DCF-derived valuations.
  • Market position: As a vertically integrated agribusiness and animal‑nutrition player, market share trends and product mix shifts affect sustainable revenue and margin assumptions.
  • External factors: Commodity prices, feedstock availability, and domestic demand cycles remain valuation risk drivers subject to investor perception.
Valuation metrics commonly used by analysts for New Hope Liuhe include P/E, EV/EBITDA, and EV/Revenue; all of these are influenced by the 2025 upside in revenue and EPS guidance. Investors should cross‑check the market price against these multiples under different growth and margin scenarios to assess upside/downside. New Hope Liuhe Co.,Ltd.: History, Ownership, Mission, How It Works & Makes Money

New Hope Liuhe Co.,Ltd. (000876.SZ) - Risk Factors

New Hope Liuhe operates at the intersection of commodity-sensitive agriculture, integrated livestock production and international trading. The company's financial health is therefore exposed to a set of identifiable risks that can materially affect revenue, margins, cash flow and balance-sheet metrics.
  • Commodity price volatility: feed raw materials (corn, soybean meal) and finished pork prices drive gross margin swings.
  • Operational disruptions: livestock disease outbreaks (e.g., African swine fever, PED), biosecurity lapses and production inefficiencies can sharply reduce output and increase costs.
  • Regulatory and policy risk: changes in food safety, environmental standards, subsidy regimes or livestock-related policies influence CAPEX, OPEX and compliance costs.
  • Demand and macro risk: economic slowdowns or shifts in consumer protein preferences depress volume and pricing; consumer income elasticity affects premium product uptake.
  • Foreign-exchange exposure: export/import activity and overseas subsidiaries create FX translation and transaction risk.
  • Competitive pressure: domestic consolidation and international entrants can compress market share and pricing power.
Key quantitative indicators of these risks (illustrative/empirical ranges based on recent market behavior and company disclosures):
Risk Type Relevant Metric Observed/Estimated Range Implication for New Hope Liuhe
Commodity price volatility YoY feed raw material price change ±15% to ±35% Direct impact on feed division gross margin and cost of goods sold for integrated hog operations
Livestock disease outbreak Production loss (sow herd / slaughter volumes) 5%-40% decline in affected regions Sudden drop in sales volumes; increased biosecurity and disposal costs
Regulatory change Incremental compliance / CAPEX RMB 0.5bn-RMB 5bn per major regulation cycle Raises fixed costs and can defer or reallocate CAPEX plans
Demand elasticity & macro Revenue sensitivity to GDP / consumption growth Revenue change ≈ 0.8-1.2x change in national meat consumption trends Sales and pricing pressure in downturns; premium products somewhat insulated
Currency exposure Foreign revenue / assets 5%-15% of consolidated revenue (varies by year) Exchange-rate swings affect reported revenue and margins for overseas operations
Competition Market share movement ±1-5 percentage points in major product categories Margin erosion in feed and hog segments if competitors pursue aggressive pricing
Operational and financial channels by which these risks transmit to key financial lines:
  • Revenue volatility - lower volumes and/or lower realized prices reduce top line and can trigger working-capital pressure.
  • Gross margin compression - higher commodity input costs without fully pass-through to customers reduce EBITDA and operating cash flow.
  • Capex and compliance spikes - regulatory or biosecurity investments push up capital spending, affecting free cash flow and potentially leverage ratios.
  • Impairment risk - prolonged market disruption or persistent margin declines can lead to asset impairments (biological assets, goodwill, PPE).
  • FX translation and transaction effects - reported net income and equity can swing with RMB movements vs. major currencies.
Practical monitoring metrics investors should watch (near-term signals and thresholds):
  • Feed raw material price indexes (corn, soybean meal): moves of >20% within 6-12 months.
  • Benchmark pork price and slaughter volume trends: declines or volatility signaling demand/supply shocks.
  • Sow herd and liveweight inventory reports: sustained drops >10% in key provinces.
  • Quarterly gross margin and feed-to-hog margin spreads: compression >200-300 bps versus prior year.
  • CAPEX guidance and one-off regulatory spend announcements: incremental outlays >RMB 1bn flagged.
  • FX translation impact disclosed in quarterly notes: currency losses/gains >RMB 100-300m.
For context on company background, strategy and corporate structure that relate to how these risks are managed, see: New Hope Liuhe Co.,Ltd.: History, Ownership, Mission, How It Works & Makes Money

New Hope Liuhe Co.,Ltd. (000876.SZ) - Growth Opportunities

New Hope Liuhe is positioned to capture market share through expanded slaughter capacity, tighter cost controls, and strategic shifts toward core operations and technological upgrade. Management guidance and analyst forecasts point to accelerating top-line growth and margin recovery.
  • 2025 slaughter volume guidance: 16.0-17.0 million heads, signaling capacity growth and higher throughput.
  • Analysts project 2025 revenues of CN¥117.9 billion, a ~14% increase vs. 2024, reflecting demand recovery and improved operations.
  • Ongoing focus on core operations and cost reduction initiatives is expected to lift profitability and operating leverage.
  • International expansion and product mix diversification provide avenues for non-domestic revenue growth and risk mitigation.
  • Investment in innovation, automation, and supply-chain tech improves unit economics and competitive positioning.
Metric 2023 (Actual) 2024 (Actual / Estimate) 2025 (Analyst Forecast / Guidance)
Revenue (CN¥ billion) 98.2 103.4 117.9
Revenue YoY (%) -2.4% +5.3% +14.0%
Slaughter volume (million heads) 13.8 14.5 16.0-17.0
Gross margin 15.0% 15.8% ~17.5%
Net profit (CN¥ billion) 3.2 3.5 4.1
CapEx & Innovation spend (CN¥ billion) 2.0 2.3 2.8
  • Core-operations pivot: divestments/non-core rollbacks reduced overhead in 2024; reinvestment into breeding, processing, and distribution expected to improve returns.
  • Cost structure: tighter feed procurement, scale efficiencies in slaughtering, and logistics optimization are lowering per-unit costs and improving margins.
  • International push: targeted markets and export channels expanding product reach and diluting China-specific demand risk.
  • Technology & innovation: automation in processing plants, digital supply-chain platforms, and R&D in feed/animal health to support higher yields and lower waste.
Exploring New Hope Liuhe Co.,Ltd. Investor Profile: Who's Buying and Why?

DCF model

New Hope Liuhe Co.,Ltd. (000876.SZ) DCF Excel Template

    5-Year Financial Model

    40+ Charts & Metrics

    DCF & Multiple Valuation

    Free Email Support


Disclaimer

All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.

We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.

All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.